CBP-mediated FOXO-1 Acetylation Inhibits Pancreatic Tumor Growth by Targeting SirT
Overview
Affiliations
Here, we investigated the potential mechanism of capsaicin-mediated apoptosis in pancreatic cancer cells. Capsaicin treatment phosphorylated c-jun-NH2-kinase (JNK); forkhead box transcription factor, class O (FOXO1); and BIM in BxPC-3, AsPC-1, and L3.6PL cells. The expression of BIM increased in response to capsaicin treatment. Capsaicin treatment caused cleavage of caspase-3 and PARP, indicating apoptosis. Antioxidants tiron and PEG-catalase blocked capsaicin-mediated JNK/FOXO/BIM activation and protected the cells from apoptosis. Furthermore, capsaicin treatment caused a steady increase in the nuclear expression of FOXO-1, leading to increased DNA binding. Capsaicin-mediated expression of BIM was found to be directly dependent on the acetylation of FOXO-1. The expression of CREB-binding protein (CBP) was increased, whereas SirT-1 was reduced by capsaicin treatment. Using acetylation mimic or defective mutants, our result demonstrated that phosphorylation of FOXO-1 was mediated through acetylation by capsaicin treatment. JNK inhibitor attenuated the phosphorylation of FOXO-1, activation of BIM, and abrogated capsaicin-induced apoptosis. Moreover, silencing FOXO1 by siRNA blocked capsaicin-mediated activation of BIM and apoptosis, whereas overexpression of FOXO-1 augmented its effects. Silencing Bim drastically reduced capsaicin-mediated cleavage of caspase-3 and PARP, indicating the role of BIM in apoptosis. Oral administration of 5 mg/kg capsaicin substantially suppressed the growth of BxPC-3 tumor xenografts in athymic nude mice. Tumors from capsaicin-treated mice showed an increase in the phosphorylation of JNK, FOXO-1, BIM, and levels of CBP, cleavage of caspase-3, PARP, and decreased SirT-1 expression. Taken together, our results suggest that capsaicin activated JNK and FOXO-1, leading to the acetylation of FOXO-1 through CBP and SirT-1. Acetylated FOXO1 induced apoptosis in pancreatic cancer cells through BIM activation.
Chen J, Shen Z, Chen B, Liu S, Mei Y, Li K Stem Cell Res Ther. 2025; 16(1):105.
PMID: 40025506 PMC: 11872336. DOI: 10.1186/s13287-025-04245-1.
The role of acetylation and deacetylation in cancer metabolism.
Wang C, Ma X Clin Transl Med. 2025; 15(1):e70145.
PMID: 39778006 PMC: 11706801. DOI: 10.1002/ctm2.70145.
Forkhead box O proteins: steering the course of stem cell fate.
Cheng M, Nie Y, Song M, Chen F, Yu Y Cell Regen. 2024; 13(1):7.
PMID: 38466341 PMC: 10928065. DOI: 10.1186/s13619-024-00190-1.
Tan L, Wang S, Huang S, Tie Y, Sai N, Mao Y Cancer Sci. 2024; 115(4):1224-1240.
PMID: 38403332 PMC: 11006996. DOI: 10.1111/cas.16120.
Acetylation of FOXO1 activates Bim expression involved in CVB3 induced cardiomyocyte apoptosis.
Hu Y, Yi L, Yang Y, Wu Z, Kong M, Kang Z Apoptosis. 2023; 29(7-8):1271-1287.
PMID: 38127284 PMC: 11263423. DOI: 10.1007/s10495-023-01924-3.